期刊文献+

减肥保健食品中违禁添加双胍类西药的分析方法研究 被引量:1

Study on determination of illegal drugs metformin and phenformin added in the weight-loss functional foods
下载PDF
导出
摘要 目的:建立测定减肥保健食品中违禁添加二甲双胍和苯乙双胍的超高效液相色谱-串联质谱分析方法,并通过研究其质谱特征,推测质谱裂解途径。方法:不同基质类型的减肥保健食品超声提取15min,经弱阳离子交换固相萃取小柱WCX净化后,以ACQUITY UPLC BEH HILIC(1.7μm,100mm×2.1mm)分离,进行UPLC-MS/MS多反应监测模式下的定性及定量分析。结果:苯乙双胍在0.1~50μg/L的范围内呈良好的线性关系,相关系数为0.9996;二甲双胍在0.05~50μg/L的范围内呈良好的线性关系,相关系数为0.9995。在3个添加水平范围内的平均回收率为80.7%~96.3%;日内精密度均小于8%,日间精密度均小于10%。结论:本方法分析速度快,灵敏度高,回收率好,可用于不同减肥保健食品中违禁添加二甲双胍和苯乙双胍的同时检测。 Objective:To develop a simple and rapid analytical method for the simultaneous determination of metformin and phenformin in the weight-loss functional foods by ultra performance liquid chromatography tandem mass spectrometry and study mass spectra characterization in order to speculate on fragmentation pathways. Methods.Various weight-loss functional foods were extracted under ultrasonication in 15min and purified by WCX column. Qualitative and quantitative analysis was carried out for the samples under the MRM mode after the chromatographic separation on ACQUITY UPLC BEH HILIC column (1.7um,100mm×2.1mm). Results : phenformin was linear in the range 0.1 -50ug/L and the linear correlation coefficient reached 0.9996; metformin was linear in the range 0.05-50ug/L and the linear correlation coefficient reached 0.9995. The method recoveries at the three spiked levels (low,middle,high) were 80.7%-96.3%,with the intra-day precision less than 8% and the Inter-day precision less than 10%. Conclusion:The method was reliable,sensitive,high recovery and adapts to the determination of metformin and phenformin in the weight-loss functional foods.
出处 《食品工业科技》 CAS CSCD 北大核心 2011年第10期431-434,共4页 Science and Technology of Food Industry
基金 国家质检总局科技计划项目(2009IK310)
关键词 减肥保健食品 超高效液相色谱-串联质谱 二甲双胍 苯乙双胍 质谱裂解途径 the weight-loss functional foods ultra performance liquid chromatography tandem masss pectrometry metformin phenformin mass spectrum fragmentation pathways
  • 相关文献

参考文献12

  • 1彭红.二甲双胍和格列酮类药物对肥胖T_2DM作用研究进展[J].实用糖尿病杂志,2008,4(1):12-13. 被引量:2
  • 2郄文娟,冯俊贤,黄鸿雁,佘云,于立新.两点电位滴定法测定盐酸二甲双胍[J].理化检验(化学分册),2002,38(12):632-633. 被引量:14
  • 3黄薇.荷移光度法测定盐酸二甲双胍的含量[J].德州学院学报,2004,20(4):40-41. 被引量:8
  • 4Hassan S M S,Mahmoud W H,Elmosallamy A F M,et al. Determination of metformin in pharmaceutical preparations using potentiometry,spectroflu--orimetryand UV--visible speetrophotometry [J]. Anal Chim Acta, 1999,378:299-311.
  • 5王国俊 付平.紫外分光光度法测定复方罗格列酮盐酸二甲双胍片中盐酸二甲双胍的含量.西部药学,4(4):238-239.
  • 6方卢秋.NBSM-荧光素体系流动注射化学发光法测定盐酸二甲双胍[J].理化检验(化学分册),2003,39(9):512-514. 被引量:12
  • 7Edward P C,Sherry Y. Solid phase extraction-Non-aqueous capillary electrophoresis for determination of metformin,phenformin and glyburide in human plasma [J]. Chromatography B,2006, 843: 94-99.
  • 8Amini H,Ahmadiani A,Gazerani P. Determination of metformin in human plasma by high-performance liquid chromatography[J]. Chromatography B, 2005,824:319-322.
  • 9Porta V,Schramm S G, Kano E K,et al. HPLC-UV determination of metformin in human plasma forapplication in pharmacokinetics and bioequivalence studies [J]. Pharm Biomed Anal,2008,46: 143-147.
  • 10Mistri H N,Jangid A G,Shrivastav P S. Liquid chromatography tandem mass spectrometry method for simultaneous determination of antidiabetic drugs metformin and glyburide in human plasma [J]. Pharm Biomed Anal,2007,45: 97-106.

二级参考文献27

  • 1陈俊杰,冯军,李焕德,孙银香,张毕奎.HPLC法同时测定二甲双胍等5种降血糖药物[J].中南药学,2003,1(1):34-35. 被引量:10
  • 2冯俊贤,李素娟,尹湘红,宋丽英.两点电位滴定法测定调味品中氯化钠[J].中国调味品,1994,19(4):26-27. 被引量:6
  • 3叶任高.内科学(第五版)[M].北京:人民卫生出版社,2000.857.
  • 4[2]kirpichnikovd.mdarlan S,Sowers TR,Metforninan update.Annntem Med 2002;137:25-33.
  • 5[3]Escherp,Wahliw.Peroxisome proliferator-activated receptors:Insight into multiple celhlar functinons MutRes 2000;448:121-138.
  • 6[4]Dubois M.Vantyghem M C,Schoonjans K,et al.Thiamlidinediones in type 2 diabetes.Role of peroxisolne proliferator-activated receptor gamma(PPARgamma).Ann Endocrinol 2002;63;511-523.
  • 7[5]Kumsr N,Dey C S.Development of insulin resistance and reversal by Thiazolidineiones in C2C12 skeletal muscle cells.Biochem Pharmacol 2003;65:249-257.
  • 8[6]Porter L E,Freed MI,Jones NP,et al.Rosiglitszone improves cellfunction as measured by proinsulin insulin ratio in patients with type 2 diabetes.Diabetes 2000;49(Suppl 1);A122.
  • 9[7]Lindsay RS,Funahashi T,Hanson RL,et al,Adiponectin and development of type 2 diabetes in the Pima Indian population.Lancet 2002;360:57-58.
  • 10[8]Combs TP,Wagner JA,Berger J,et al.Induction of adipocyte complement-related protein of 30 kilodidtons by PPARgemma agonists:a potential mechanism of insulin sensitization.Endocrinology 2002;143:998-1007.

共引文献22

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部